Qin T - Search Results

1

Prognostic mutations in persons with isolated neutropenia myelodysplastic syndrome.

Shi Z, Qin T, Xu Z, Li B, Huang H, Zhang H, Fang L, Pan L, Hu N, Qu S, Huang G, Gale RP, Xiao Z. Shi Z, et al. Among authors: qin t. Leuk Lymphoma. 2019 Nov;60(11):2835-2837. doi: 10.1080/10428194.2019.1607324. Epub 2019 May 6. Leuk Lymphoma. 2019. PMID: 31056995 Free PMC article. No abstract available.

2

Periodic oscillation of blood leukocytes, platelets, and hemoglobin in a patient with chronic eosinophilic leukemia.

Xiao Z, Hao Y, Qin T, Han Z. Xiao Z, et al. Among authors: qin t. Leuk Res. 2003 Jan;27(1):89-91. doi: 10.1016/s0145-2126(02)00097-8. Leuk Res. 2003. PMID: 12479858

3

Unique cytogenetic features of primary myelodysplastic syndromes in Chinese patients.

Li L, Liu XP, Nie L, Yu MH, Zhang Y, Qin TJ, Xiao ZJ. Li L, et al. Leuk Res. 2009 Sep;33(9):1194-8. doi: 10.1016/j.leukres.2008.11.021. Epub 2009 Jan 6. Leuk Res. 2009. PMID: 19128829

4

[Re-evaluation of classification of myelodysplastic syndromes with low percentage bone marrow blasts].

Yu MH, Xu ZF, Li L, Nie L, Liu L, Zhang Y, Qin TJ, Hao YS, Xiao ZJ. Yu MH, et al. Zhonghua Xue Ye Xue Za Zhi. 2009 Jan;30(1):3-7. Zhonghua Xue Ye Xue Za Zhi. 2009. PMID: 19563026 Chinese.

5

[Study on karyotypic abnormalities and its prognostic significance in Chinese patients with primary myelodysplastic syndromes].

Li L, Liu XP, Nie L, Yu MH, Zhang Y, Qin TJ, Xiao ZJ. Li L, et al. Zhonghua Xue Ye Xue Za Zhi. 2009 Apr;30(4):217-22. Zhonghua Xue Ye Xue Za Zhi. 2009. PMID: 19731819 Chinese.

6

[The prognostic value of a modified WPSS based on routine laboratory parameters in patients with myelodysplastic syndromes: a preliminary result].

Li L, Nie L, Yu MH, Yu Y, Liu L, Qin TJ, Xu ZF, Zhang Y, Xiao ZJ. Li L, et al. Zhonghua Xue Ye Xue Za Zhi. 2009 May;30(5):313-7. Zhonghua Xue Ye Xue Za Zhi. 2009. PMID: 19799126 Chinese.

7

[Clinical study on regimen cyclophosphamide, Ara-C and topotecan (CAT) in treatment of patients with refractory or relapsed acute myelogenous leukemia].

Qin TJ, Xu ZF, Wang JY, Zhou CL, Xiao ZJ. Qin TJ, et al. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2009 Oct;17(5):1342-6. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2009. PMID: 19840480 Clinical Trial. Chinese.

8

[The efficacy of imatinib mesylate for patients with myeloproliferative neoplasm (MPN) with eosinophilia].

Zhang Y, Qin TJ, Zhou CL, Liu L, Xiao ZJ. Zhang Y, et al. Zhonghua Xue Ye Xue Za Zhi. 2009 Jun;30(6):381-4. Zhonghua Xue Ye Xue Za Zhi. 2009. PMID: 19951530 Clinical Trial. Chinese.

9

[Low-dose melphalan therapy for patients with intermediate- to high-risk myelodysplastic syndromes].

Liu L, Qin TJ, Xu ZF, Zhou CL, Zhang Y, Xiao ZJ. Liu L, et al. Zhonghua Xue Ye Xue Za Zhi. 2009 Jul;30(7):443-5. Zhonghua Xue Ye Xue Za Zhi. 2009. PMID: 19954594 Clinical Trial. Chinese.

10

Low-dose melphalan in myelodysplastic syndromes: an effective treatment for elderly RAEB-I or II patients?

Xiao Z, Liu L, Xu Z, Qin T, Zhang Y, Zhang T. Xiao Z, et al. Among authors: qin t. Leuk Lymphoma. 2010 Mar;51(3):549-51. doi: 10.3109/10428190903515200. Leuk Lymphoma. 2010. PMID: 20038270 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,143 results

Search Page

Filters